Free Trial

BellRing Brands (BRBR) Stock Forecast & Price Target

BellRing Brands logo
$78.60 +2.11 (+2.76%)
(As of 11/22/2024 ET)

BellRing Brands - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
12

Based on 15 Wall Street analysts who have issued ratings for BellRing Brands in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 3 have given a hold rating, and 12 have given a buy rating for BRBR.

Consensus Price Target

$74.27
-5.51% Downside
According to the 15 analysts' twelve-month price targets for BellRing Brands, the average price target is $74.27. The highest price target for BRBR is $84.00, while the lowest price target for BRBR is $55.00. The average price target represents a forecasted downside of -5.51% from the current price of $78.60.
Get the Latest News and Ratings for BRBR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for BellRing Brands and its competitors.

Sign Up

BRBR Analyst Ratings Over Time

TypeCurrent Forecast
11/24/23 to 11/23/24
1 Month Ago
10/25/23 to 10/24/24
3 Months Ago
8/26/23 to 8/25/24
1 Year Ago
11/24/22 to 11/24/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
11 Buy rating(s)
11 Buy rating(s)
13 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$74.27$65.71$62.64$46.93
Forecasted Upside-5.51% Downside0.99% Upside13.01% Upside-6.05% Downside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

BRBR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BRBR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

BellRing Brands Stock vs. The Competition

TypeBellRing BrandsMedical CompaniesS&P 500
Consensus Rating Score
2.80
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside-5.51% Downside27,098.21% Upside7.66% Upside
News Sentiment Rating
Positive News

See Recent BRBR News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/21/2024Barclays
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$74.00 ➝ $79.00+6.21%
11/20/2024Mizuho
2 of 5 stars
 Boost TargetOutperform ➝ Outperform$72.00 ➝ $80.00+7.77%
11/20/2024Citigroup
3 of 5 stars
 Boost TargetBuy ➝ Buy$72.00 ➝ $83.00+11.81%
11/20/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$70.00 ➝ $78.00+5.08%
11/20/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$60.00 ➝ $75.00+1.04%
11/20/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$67.00 ➝ $81.00+10.53%
11/20/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$75.00 ➝ $82.00+11.90%
11/20/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$73.00 ➝ $77.00+5.08%
11/19/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$75.00 ➝ $75.00+2.38%
11/14/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$61.00 ➝ $84.00+16.25%
8/7/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$65.00 ➝ $64.00+18.61%
8/6/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$55.00 ➝ $55.00+0.02%
8/6/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$66.00 ➝ $66.00+33.85%
5/8/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$64.00 ➝ $70.00+19.84%
3/7/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$61.00 ➝ $65.00+5.30%
4/26/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Andersen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
2/8/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$36.00 ➝ $42.00+40.33%
12/14/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$31.00+23.41%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:01 AM ET.


BRBR Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for BellRing Brands is $74.27, with a high forecast of $84.00 and a low forecast of $55.00.

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BellRing Brands in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" BRBR shares.

According to analysts, BellRing Brands's stock has a predicted downside of -5.51% based on their 12-month stock forecasts.

BellRing Brands has been rated by research analysts at Bank of America, Barclays, Citigroup, DA Davidson, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group, Mizuho, Stifel Nicolaus, and Truist Financial in the past 90 days.

Analysts like BellRing Brands less than other "medical" companies. The consensus rating score for BellRing Brands is 2.80 while the average consensus rating score for "medical" companies is 2.80. Learn more on how BRBR compares to other companies.


This page (NYSE:BRBR) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners